Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: Methylene blue associated with maghemite nanoparticles has antitumor activity in breast and ovarian carcinoma cell lines

Fig. 2

Cytotoxicity of MAGCIT–MB and free MB after 24, 48 and 72 h. a A2780, c T-47D, e MDA-MB-231, g HUVEC and i HNTMC cell viability after exposure to MAGCIT–MB. b A2780, d T-47D, f MDA-MB-231, h HUVEC and j HNTMC cell viability after exposure to free MB. Bars represent cell viability in percentage after treatments at the indicated concentrations. The data represent the mean ± SEM of three independent experiments in triplicate. *p < 0.05; **p < 0.01, ***p < 0.001 and ****p < 0.0001. *Treatment compared to NT control

Back to article page